ClinicalTrials.Veeva

Menu
A

Advanced Research, LLC | Coral Springs, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Filgotinib
Pertuzumab
Itraconazole
RBM-007
Fluocinolone Acetonide
PL-8177
Ritonavir
CT1812

Parent organization

This site is a part of Advanced Research, LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 11 total trials

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced sol...

Enrolling
HER2-positive Advanced Solid Tumor
Drug: Itraconazole
Drug: Ritonavir

This study aims to evaluate the efficacy, safety and tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of efgartigimod P...

Enrolling
Thyroid Eye Disease
Other: Placebo PH20 SC
Combination Product: Efgartigimod PH20 SC

This study is a pivotal study to evaluate the efficacy and safety of a single injection of autologous adipose-derived SVF produced using the GID SVF-...

Enrolling
Osteoarthritis, Knee
Device: GID SVF-2 Device System

A study to evaluate the safety and efficacy of YUTIQ® 0.18 mg intravitreal implant for the management of chronic non-infectious posterior segment uve...

Active, not recruiting
Uveitis, Posterior
Drug: Fluocinolone Acetonide Intravitreal Implant 0.18 mg

The purpose of this study is to compare PL8177 (a melanocortin receptor agonist) to placebo (in a 3:1 ratio-meaning that for every 3 people that get...

Enrolling
Ulcerative Colitis Flare
Ulcerative
Drug: PL8177 Placebo
Drug: PL8177
Locations recently updated

This is a Phase 2, prospective, multicenter, randomized, double-masked, placebo-controlled 104-week study to assess the efficacy, safety, and tolerab...

Enrolling
Age-Related Macular Degeneration
Drug: Active Comparator CT1812
Drug: Placebo Comparator

Trial sponsors

G
A
Cognition Therapeutics logo
D
G
Novartis logo
P
R
Roche logo
argenx logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems